Bio-Connect

InVivoMAb anti-mouse IL-6

BE0046
Bio X Cell
ApplicationsNeutralisation/Blocking
Product group Antibodies
ReactivityMouse
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse IL-6
  • Delivery Days Customer
    7
  • Applications
    Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    MP5-20F3
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG1
  • Reactivity
    Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Benevides L, da Fonseca DM, Donate PB, et al. IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. Cancer Res. 2015,75(18):3788-99. doi: 10.1158/0008-5472.CAN-15-0054
    Read this paper
  • Liang Y, Yang K, Guo J, et al. Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Sci Rep. 2015,5:10406. doi: 10.1038/srep10406
    Read this paper
  • Tsukamoto H, Senju S, Matsumura K, et al. IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age. Nat Commun. 2015,6:6702. doi: 10.1038/ncomms7702
    Read this paper
  • Jose S, Tan SW, Ooi YY, et al. Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-α levels. J Neuroinflammation. 2014,11:149. doi: 10.1186/s12974-014-0149-8
    Read this paper
  • Khmaladze Ia, Kelkka T, Guerard S, et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc Natl Acad Sci U S A. 2014,111(35):E3669-78. doi: 10.1073/pnas.1405798111
    Read this paper
  • Hock K, Pilat N, Baranyi U, et al. Donor CD4 T cells trigger costimulation blockade-resistant donor bone marrow rejection through bystander activation requiring IL-6. Am J Transplant. 2014,14(9):2011-22. doi: 10.1111/ajt.12823
    Read this paper
  • Barber DL, Andrade BB, McBerry C, et al. Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. J Immunol. 2014,192(2):676-82. doi: 10.4049/jimmunol.1301004
    Read this paper
  • Kugler DG, Mittelstadt PR, Ashwell JD, et al. CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J Exp Med. 2013,210(10):1919-27. doi: 10.1084/jem.20122300
    Read this paper
  • Berger H, Végran F, Chikh M, et al. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. Cancer Res. 2013,73(12):3578-90. doi: 10.1158/0008-5472.CAN-12-4018
    Read this paper
  • Debock I, Delbauve S, Dubois A, et al. Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived mice. Am J Transplant. 2012,12(1):81-9. doi: 10.1111/j.1600-6143.2011.03778.x
    Read this paper